Consumer Product Safety Clinical Trials

• Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00487786 - Recruiting
  Neoplasms
  
• A Prospective Safety Follow Up Study Of Subjects Enrolled In Study A4321001 And Who Have Received Drug Product
  ClinicalTrials.gov Identifier: NCT00471224 - Recruiting
  Siderosis
  
• Safe Water Techniques in Kenya
  ClinicalTrials.gov Identifier: NCT00531869 - Not yet recruiting
  Consumer Willingness to Pay for POU Products; Consumer Preferences and Use of POU Products
  
• A Study to Evaluate the Safety and Efficacy of Eurand Pancreatic Enzyme Product (PEP) in Patients With Cystic Fibrosis and Exocrine Pancreatic Insufficiency
  ClinicalTrials.gov Identifier: NCT00297167 - Recruiting
  Cystic Fibrosis; Exocrine Pancreatic Insufficiency
  
• Evaluation of DermStream(Tm) - an Irrigation Product for Chronic Wound Management
  ClinicalTrials.gov Identifier: NCT00310752 - Recruiting
  Foot Ulcer
  
• Efficacy of Combination Product (Sumatriptan Succinate/Naproxen Sodium) in Eletriptan Non-Responders.
  ClinicalTrials.gov Identifier: NCT00382993 - Recruiting
  Migraine
  
• Efficacy of Combination Product (Sumatriptan Succinate/Naproxen Sodium) in Eletriptan Non-Responders.
  ClinicalTrials.gov Identifier: NCT00383162 - Recruiting
  Migraine
  
• A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-Term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.
  ClinicalTrials.gov Identifier: NCT00386607 - Active, not recruiting
  Hypertension
  
• A Survey on Consumer Use of Over-the-Counter (OTC) Nicotine Patches - 1
  ClinicalTrials.gov Identifier: NCT00134927 - Active, not recruiting
  Tobacco Use Disorder; nicotine
  
• Improving Pediatric Safety and Quality with Health Care Information Technology
  ClinicalTrials.gov Identifier: NCT00134823 - Active, not recruiting
  MEDICATION ERRORS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; PATIENT SAFETY; QUALITY IMPROVEMENT
  
• Study to Test a Marketed Product in the Treatment of Migraine-Associated Nausea
  ClinicalTrials.gov Identifier: NCT00250458 - Active, not recruiting
  Migraine
  
• Effects of Nutritional Supplementation (Product 4808) on Acute Skeletal Muscle Protein Synthesis in Cancer Patients
  ClinicalTrials.gov Identifier: NCT00446888 - Recruiting
  Colorectal Cancer
  
• Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00003456 - Active, not recruiting
  adult glioblastoma
  
• Trial of an Anti-HIV-1 Gene Transfer Product
  ClinicalTrials.gov Identifier: NCT00074997 - Active, not recruiting
  HIV Infections
  
• Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003489 - Active, not recruiting
  Head and Neck Cancer
  
• Safety of AEB071 in Healthy Volunteers and to Compare the Ethnicity, Metabolic, and Safety Effects Between Caucasian and Japanese Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00416546 - Recruiting
  Healthy
  
• A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)
  ClinicalTrials.gov Identifier: NCT00417469 - Completed
  Facial Wrinkles
  
• A Clinical Double Blind, Randomized Study of the Efficacy of Hyperuricemia Treatment With Anserine Product.
  ClinicalTrials.gov Identifier: NCT00208000 - Recruiting
  "Hyperuricemia,Anserine"
  
• Booster Vaccination Study to Assess Immune Response & Safety of a Dose of GSK Biologicals’ Mencevax™ ACWY at 24-30 Mths Age & to Assess Immune Response & Safety of 1/5th of a Dose of Mencevax™ ACWY at 30-36 Mths Age in Subjects Primed in
  ClinicalTrials.gov Identifier: NCT00291343 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases; Neisseria Meningitidis Serogroups A & C Diseases
  
• Safety and Immunogenicity of FluBlok in Pediatrics
  ClinicalTrials.gov Identifier: NCT00336453 - Active, not recruiting
  Influenza
  
• Safety and Efficacy Study of Hydromorphone and Morphine
  ClinicalTrials.gov Identifier: NCT00195910 - Active, not recruiting
  Pain
  
• Immunogenicity and Safety of Verorab™ in Indian Population
  ClinicalTrials.gov Identifier: NCT00260351 - Active, not recruiting
  Rabies
  
• A Trial to Evaluate the Shedding and Safety of CAIV-T
  ClinicalTrials.gov Identifier: NCT00344305 - Active, not recruiting
  Healthy
  
• Study of Safety and Efficacy of an Oral Contraceptive
  ClinicalTrials.gov Identifier: NCT00391807 - Active, not recruiting
  Contraception
  
• MK0974 Long Term Safety Study
  ClinicalTrials.gov Identifier: NCT00443209 - Active, not recruiting
  Migraine
  
• Safety, Blood Levels and Effects of GW642444
  ClinicalTrials.gov Identifier: NCT00469040 - Active, not recruiting
  Asthma
  
• Study of Safety and Efficacy of an Oral Contraceptive
  ClinicalTrials.gov Identifier: NCT00477633 - Active, not recruiting
  Contraception
  
• Efficacy and Safety of Grasspollen Sublingual Immunotherapy
  ClinicalTrials.gov Identifier: NCT00567346 - Active, not recruiting
  Rhinoconjunctivitis
  
• Antineoplaston Therapy in Treating Patients With Ependymoma
  ClinicalTrials.gov Identifier: NCT00003479 - Active, not recruiting
  adult ependymoma; newly diagnosed childhood ependymoma; recurrent childhood ependymoma; adult anaplastic ependymoma
  
• Safety and Effectiveness of D-Cycloserine in Children With Autism
  ClinicalTrials.gov Identifier: NCT00198120 - Active, not recruiting
  Autistic Disorder
  
• Safety and Immunogenicity of the 2005-2006 Fluzone® Vaccine
  ClinicalTrials.gov Identifier: NCT00258830 - Active, not recruiting
  Influenza
  
• Safety of Imovax Polio in Chinese Infants and Children
  ClinicalTrials.gov Identifier: NCT00258843 - Active, not recruiting
  Poliomyelitis
  
• Immunogenicity and Safety of ADACEL™ in Taiwan
  ClinicalTrials.gov Identifier: NCT00258908 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis
  
• Safety and Efficacy of Exenatide as Monotherapy
  ClinicalTrials.gov Identifier: NCT00381342 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Efficacy and Safety of THR-4109 in Obese Subjects
  ClinicalTrials.gov Identifier: NCT00485017 - Active, not recruiting
  Obesity
  
• Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and Rituxan
  ClinicalTrials.gov Identifier: NCT00496873 - Active, not recruiting
  Lymphoma
  
• Safety, Tolerability and Pharmacokinetic Study of Biota-CS-8958
  ClinicalTrials.gov Identifier: NCT00311714 - Active, not recruiting
  Influenza
  
• Efficacy and Safety Study of an Oral Contraceptive in Healthy Females
  ClinicalTrials.gov Identifier: NCT00206583 - Active, not recruiting
  Contraception
  
• STEPS Trial – Spheramine Safety and Efficacy Study
  ClinicalTrials.gov Identifier: NCT00206687 - Active, not recruiting
  Parkinson Disease
  
• StaphVAX Immunogenicity and Safety in Orthopaedic Joint Surgery
  ClinicalTrials.gov Identifier: NCT00211965 - Active, not recruiting
  Staphylococcal Infections
  
• Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00247260 - Active, not recruiting
  Liver Cancer
  
• Safety and Efficacy Study of rEV131 in Allergic Rhinitis
  ClinicalTrials.gov Identifier: NCT00247520 - Active, not recruiting
  Hay Fever
  
• Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding
  ClinicalTrials.gov Identifier: NCT00307801 - Active, not recruiting
  Metrorrhagia
  
• Efficacy and Safety Trial of SLITone Birch in Subjects With Hayfever
  ClinicalTrials.gov Identifier: NCT00310466 - Active, not recruiting
  Allergy
  
• An Evaluation of the Long-Term Safety of Alpharen™
  ClinicalTrials.gov Identifier: NCT00358722 - Active, not recruiting
  Chronic Kidney Failure
  
• Safety Study of 7 Botulinum Antitoxin Serotypes Derived From Horses
  ClinicalTrials.gov Identifier: NCT00360737 - Active, not recruiting
  Healthy
  
• Efficacy and Safety/Tolerability of Grass MATA MPL
  ClinicalTrials.gov Identifier: NCT00414141 - Active, not recruiting
  Type I Hypersensitivity
  
• Efficacy and Safety/Tolerability of Ragweed MATA MPL
  ClinicalTrials.gov Identifier: NCT00423787 - Active, not recruiting
  Type I Hypersensitivity
  
• Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00426478 - Active, not recruiting
  Hypertension
  
• Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town
  ClinicalTrials.gov Identifier: NCT00460590 - Active, not recruiting
  Tuberculosis
  
• Assess Safety and Efficacy of Lacosamide in Patients With Partial Seizures
  ClinicalTrials.gov Identifier: NCT00515619 - Active, not recruiting
  Epilepsy
  
• Safety Study of Olpatadine Nasal Spray
  ClinicalTrials.gov Identifier: NCT00578331 - Active, not recruiting
  Perennial Allergic Rhinitis
  
• Efficacy and Safety Study of Anti-Adhesion Product in the Prevention of Intraperitoneal Adhesions
  ClinicalTrials.gov Identifier: NCT00512356 - Completed
  Intraperitoneal Adhesions
  
• Dose-Escalating Safety Study in Subjects on Stable Statin Therapy
  ClinicalTrials.gov Identifier: NCT00231569 - Active, not recruiting
  Hypercholesterolemia
  
• Safety and Immune Response of Different Pediatric Combination Vaccines.
  ClinicalTrials.gov Identifier: NCT00255047 - Active, not recruiting
  Diphtheria; Polio; Pertussis
  
• Safety and Efficacy Study of ARQ 501 in Adult Patients With Leiomyosarcoma
  ClinicalTrials.gov Identifier: NCT00310518 - Active, not recruiting
  Cancer
  
• Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants
  ClinicalTrials.gov Identifier: NCT00407082 - Active, not recruiting
  Noninfectious Posterior Uveitis
  
• Evaluation of the Safety and Efficacy of CosmetaLife™ for the Correction of Nasolabial Folds
  ClinicalTrials.gov Identifier: NCT00414544 - Active, not recruiting
  Facial Wrinkles
  
• Safety of Rabeprazole in Patients Under Multiple Treatments.
  ClinicalTrials.gov Identifier: NCT00511745 - Active, not recruiting
  Gastric Ulcer; Gastroesophageal Reflux
  
• Safety and Tolerability Study With MK0646 in Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00282737 - Active, not recruiting
  Tumors; Multiple Myeloma
  
• Study to Assess the Safety of CDP870 for up to 30 Months Following Reintroduction of Treatment
  ClinicalTrials.gov Identifier: NCT00160706 - Active, not recruiting
  Crohn's Disease
  
• Determining the Safety and Effectiveness of Olanzapine in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00183612 - Active, not recruiting
  Bipolar Disorder; Psychotic Disorders
  
• A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation
  ClinicalTrials.gov Identifier: NCT00229073 - Active, not recruiting
  Erectile Dysfunction
  
• Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)
  ClinicalTrials.gov Identifier: NCT00240877 - Active, not recruiting
  Influenza
  
• Descriptive, Post-Marketing, Passive Surveillance Safety Study of Menactra Vaccine
  ClinicalTrials.gov Identifier: NCT00254995 - Active, not recruiting
  Meningitis
  
• Study, Investigating the Efficacy and Safety of Degarelix One Month Dosing Regimens
  ClinicalTrials.gov Identifier: NCT00295750 - Active, not recruiting
  Prostate Cancer
  
• A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And Children
  ClinicalTrials.gov Identifier: NCT00297206 - Active, not recruiting
  Herpes Simplex
  
• Immunogenicity and Safety of Men ACWY in Infants (6 & 12 Months)
  ClinicalTrials.gov Identifier: NCT00310856 - Active, not recruiting
  Meningococcal Meningitis
  
• Safety Study of Imexon Treatment of Patients With Metastatic or Disseminated Malignancy
  ClinicalTrials.gov Identifier: NCT00327223 - Active, not recruiting
  Neoplasm Metastasis
  
• A Trial of the Safety and Efficacy of EcoNail™ in the Treatment of Fungus Infections of the Great Toenail
  ClinicalTrials.gov Identifier: NCT00385502 - Active, not recruiting
  Onychomycosis
  
• Safety of LBH589 Alone and in Combination With IV Docetaxel and Prednisone
  ClinicalTrials.gov Identifier: NCT00493766 - Active, not recruiting
  Hormone Refractory Prostate Cancer
  
• Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1
  ClinicalTrials.gov Identifier: NCT00519259 - Active, not recruiting
  Methamphetamine Dependence
  
• Immunogenicity and Safety of Two Adjuvant Formulations of an Egg-Derived Pandemic Vaccine
  ClinicalTrials.gov Identifier: NCT00562237 - Active, not recruiting
  Healthy Subjects
  
• Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers
  ClinicalTrials.gov Identifier: NCT00569777 - Active, not recruiting
  Allergic Conjunctivitis
  
• Efficacy and Safety of AFQ056 in Reducing L-Dopa Induced Dyskinesias in Parkinson's Disease Patients, and Safety in Combination With L-Dopa
  ClinicalTrials.gov Identifier: NCT00582673 - Recruiting
  Parkinson's Disease
  
• A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain After Hip Replacement Surgery Compared With Oxycodone and Placebo Followed by a Voluntary Open-Label Extension For Safety
  ClinicalTrials.gov Identifier: NCT00364533 - Recruiting
  Replacement, Hip; Pain Assessment; Arthralgia.; Arthroplasty
  
• A Phase III A Study to Assess the Safety of CDP870 for up to 30 Months Exposure
  ClinicalTrials.gov Identifier: NCT00160524 - Active, not recruiting
  Crohn’s Disease
  
• Efficacy and Safety of Testogel® in Men With Partial Androgen Deficiency of Aging Males (PADAM)
  ClinicalTrials.gov Identifier: NCT00185198 - Active, not recruiting
  Hypogonadism
  
• Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of ADHD
  ClinicalTrials.gov Identifier: NCT00191945 - Active, not recruiting
  Attention Deficit Hyperactivity Disorder
  
• A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia
  ClinicalTrials.gov Identifier: NCT00231621 - Active, not recruiting
  Hypertriglyceridemia; Obesity; Hyperlipidemia
  
• A Phase I Safety and Immunogenicity Study of Mix and Match of Licensed Flu Vaccine and Flumist
  ClinicalTrials.gov Identifier: NCT00231907 - Active, not recruiting
  Influenza
  
• Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY
  ClinicalTrials.gov Identifier: NCT00235222 - Active, not recruiting
  HIV
  
• A Long Term Safety Study of Infliximab (Remicade)
  ClinicalTrials.gov Identifier: NCT00261976 - Active, not recruiting
  Psoriasis; Crohn Disease; Arthritis, Rheumatoid
  
• Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma
  ClinicalTrials.gov Identifier: NCT00263640 - Active, not recruiting
  Respiratory Hypersensitivity
  
• Safety and Efficacy of the Use of Regional Anticoagulation With Citrate in Continuous Venovenous Hemofiltration
  ClinicalTrials.gov Identifier: NCT00286273 - Active, not recruiting
  Kidney Failure, Acute
  
• Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin
  ClinicalTrials.gov Identifier: NCT00288431 - Active, not recruiting
  Cancer; Sarcoma
  
• Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment With SMP-114
  ClinicalTrials.gov Identifier: NCT00296257 - Active, not recruiting
  Rheumatoid Arthritis (RA)
  
• Post-Marketing Safety Study of GSK Biologicals' Boostrix® Vaccine.
  ClinicalTrials.gov Identifier: NCT00297856 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis
  
• Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV
  ClinicalTrials.gov Identifier: NCT00319852 - Active, not recruiting
  Pertussis; Diphtheria; Poliomyelitis; Tetanus
  
• A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041 for Treatment of Vulvovaginal Atrophy
  ClinicalTrials.gov Identifier: NCT00361569 - Active, not recruiting
  Menopause
  
• A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001
  ClinicalTrials.gov Identifier: NCT00382408 - Active, not recruiting
  Respiratory Tract Diseases
  
• A Trial of the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Gamunex® in Primary Immunodeficiency
  ClinicalTrials.gov Identifier: NCT00389324 - Active, not recruiting
  Immunologic Deficiency Syndrome
  
• Comparison of the Immunogenicity, Safety and Reactogenicity of FluBlØk™, To a Licensed Vaccine In Elderly Adults
  ClinicalTrials.gov Identifier: NCT00395174 - Active, not recruiting
  Influenza
  
• Safety and Effectiveness of Aquamid as Compared to Restylane for the Aesthetic Treatment of Nasolabial Folds
  ClinicalTrials.gov Identifier: NCT00407914 - Active, not recruiting
  Facial Wrinkles
  
• A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel
  ClinicalTrials.gov Identifier: NCT00427050 - Active, not recruiting
  Actinic Keratoses
  
• Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute Schizophrenic
  ClinicalTrials.gov Identifier: NCT00428350 - Active, not recruiting
  Schizophrenia
  
• Safety, Tolerability and Immunogenicity of Two Different Formulations of MenB Vaccine, When Administered to Healthy Infants
  ClinicalTrials.gov Identifier: NCT00433914 - Active, not recruiting
  Meningococcal Disease
  
• Immunogenicity and Safety of Menactra Vaccine in Adolescents in Saudi Arabia
  ClinicalTrials.gov Identifier: NCT00444951 - Active, not recruiting
  Neisseria Meningitidis; Meningococcal Infections
  
• Immunogenicity and Safety of Sanofi Pasteur's AVAXIM 80U Pediatric Vaccine Followed by Booster Dose
  ClinicalTrials.gov Identifier: NCT00483470 - Active, not recruiting
  Hepatitis A
  
• A Study of the Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age
  ClinicalTrials.gov Identifier: NCT00551915 - Active, not recruiting
  Hepatitis B